foxo4-dri senolytic peptide animal study Frontiers The disordered p53 transactivation domain
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications FOXO4 DRI Vial 10mg Stemcode Peptides FOXO4 DRI Peptide for Cellular Senescence and Anti Aging Research FOX04 DRI Apollo Peptide Sciences
Pay in 4 interest-free payments of $5.71 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



